Recent Developments in Potential Anxiolytic Agents Targeting GABAA/BzR Complex or the Translocator Protein (18kDa) (TSPO)

Publisher： Bentham Science Publishers

E-ISSN： 1873-4294|12|4|360-370

ISSN： 1568-0266

Source： Current Topics in Medicinal Chemistry, Vol.12, Iss.4, 2012-02, pp. : 360-370

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Channel-Like Functions of the 18-kDa Translocator Protein (TSPO): Regulation of Apoptosis and Steroidogenesis as Part of the Host-Defense Response

By  

Current Pharmaceutical Design, Vol. 13, Iss. 23, 2007-08 ,pp. : 2385-2405

Bentham Science Publishers

Access to resources Recommend Favorite

Structural Requirements to Obtain Highly Potent and Selective 18 kDa Translocator Protein (TSPO) Ligands

By  

Current Topics in Medicinal Chemistry, Vol. 11, Iss. 7, 2011-04 ,pp. : 860-886

Bentham Science Publishers

Access to resources Recommend Favorite

The Translocator Protein 18 kDa (TSPO) and Its Role in Mitochondrial Biology and Psychiatric Disorders

By  

Mini Reviews in Medicinal Chemistry, Vol. 15, Iss. 5, 2015-01 ,pp. : 366-372

Bentham Science Publishers

Access to resources Recommend Favorite

Medicinal Chemistry of Indolylglyoxylamide GABAA/BzR High Affinity Ligands: Identification of Novel Anxiolytic/Non Sedative Agents

By  

Current Topics in Medicinal Chemistry, Vol. 12, Iss. 4, 2012-02 ,pp. : 286-311

Bentham Science Publishers

Access to resources Recommend Favorite

Concentration-Dependent Bimodal Effect of Specific 18 kDa Translocator Protein (TSPO) Ligands on Cell Death Processes Induced by Ammonium Chloride: Potential Implications for Neuropathological Effects Due to Hyperammonemia

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 13, Iss. 4, 2014-06 ,pp. : 574-592

Bentham Science Publishers

Access to resources Recommend Favorite